Biobanks are rich collections of data and biospecimens, specifically developed as resources for research. Cloud-based laboratory information management systems (LIMS) are emerging as a better way to store, analyze and share biospecimens, offering an opportunity for biobanks looking to invest in effective data management solutions to support these interrelated goals.READ MORE
It is an extraordinary time, but it is not an excuse for lowering scientific standards, argue Professor Jonathan Kimmelman, McGill University, and Professor Alex John London, Carnegie Mellon University, in a Policy Forum published in the journal Science . Technology Networks spoke with Kimmelman in a recent interview to gain his insights on research exceptionalism.READ MORE
Progress in artificial intelligence (AI) offers the exciting possibility of pairing it with cutting-edge lab automation, essentially automating the entire drug development pipeline, from molecular design to synthesis and testing – greatly expediting the process.READ MORE
We speak with Dr Joe Hanson from “It’s Okay to Be Smart” about some of the lessons that we can learn from the coronavirus pandemic.READ MORE
After Watson, IBM’s artificial intelligence (AI) program, shot to fame in the game show Jeopardy! in 2011, it established partnerships with prominent medical institutions to apply AI to cancer care. However, Watson’s subsequent foray into the world of oncology didn’t go anywhere near as smoothly as its domination of Jeopardy! did.READ MORE
We hear directly from experts on what we know about the ongoing coronavirus pandemic and how it is being tackled.READ MORE
The spread of COVID-19 has caused huge changes in how society functions. Scientific research has been similarly changed. Whilst efforts to fight the virus have seen huge investment in vaccine research, diagnostics and efforts to understand how the virus spreads, other fields of research have largely ground to a halt. We spoke to five scientists about how the COVID-19 outbreak is affecting them.
Companies undergoing digital transformation are beginning to realise that just implementing new software isn’t valuable unless researchers can make the most of it. In this article, Paula de Matos, a consultant at The Pistoia Alliance, outlines five technologies that will drive the development of user experience in healthcare and the life sciences in the next few years.READ MORE